Yunzhu Ruan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yunzhu Ruan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Andrea Bernasconi
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
1 shared publication- Benoit Caldairou
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
1 shared publication Braeden Badner
Research Institute of the McGill University Health Centre, Montreal
1 shared publication- David Dufresne
Faculty of Medicine and Health, Université de Sherbrooke, Montréal
1 shared publication Eleanor Hill
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
1 shared publication- Myriam Srour
Research Institute of the McGill University Health Centre, Montreal, Canada
1 shared publication
Latest Publications
- Open Access
- 22 June 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (25)
Initial negative imaging in GATOR1-associated genetic epilepsy does not preclude the existence of a focal, resectable epileptogenic zone: illustrative cases
BACKGROUND: Familial focal epilepsy with variable foci (FFEVF) is a genetic epilepsy disorder in which affected family members experience different focal seizures. Focal cortical dysplasia (FCD) is a frequent cause of drug-resistant epilepsy in the pediatric population. Patients with focal epilepsy are less frequently referred for presurgical evaluation when FCD is not identified on MRI or when they have genetic epilepsy. The authors describe the successful surgical management of 3 drug-resistant FFEVF patients who initially had either negative or inconclusive MRI studies. OBSERVATIONS: All 3 patients carried the same germline pathogenic variant in NPRL3 , a GATOR1 complex gene. In patient 1, an ill-defined signal abnormality on MRI raised the suspicion for FCD and suggested that similar occult lesions might underlie the epilepsy of her relatives, whose scan results were initially reported as negative. Each patient was thus referred for comprehensive presurgical evaluation. Through the use of advanced neuroimaging, epileptogenic zones were identified in all 3 patients, allowing for targeted resection. At the last follow-up, all had remained seizure free for more than 5 years. LESSONS: When a genetic alteration is associated with FCD, such patients warrant imaging reexamination and exhaustive presurgical evaluation with advanced neuroimaging, as eventual lesion detection and subsequent resection can lead to long-term seizure freedom. https://thejns.org/doi/10.3171/CASE26127
- 22 June 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (25)
Open AccessInitial negative imaging in GATOR1-associated genetic epilepsy does not preclude the existence of a focal, resectable epileptogenic zone: illustrative cases
BACKGROUND: Familial focal epilepsy with variable foci (FFEVF) is a genetic epilepsy disorder in which affected family members experience different focal seizures. Focal cortical dysplasia (FCD) is a frequent cause of drug-resistant epilepsy in the pediatric population. Patients with focal epilepsy are less frequently referred for presurgical evaluation when FCD is not identified on MRI or when they have genetic epilepsy. The authors describe the successful surgical management of 3 drug-resistant FFEVF patients who initially had either negative or inconclusive MRI studies. OBSERVATIONS: All 3 patients carried the same germline pathogenic variant in NPRL3 , a GATOR1 complex gene. In patient 1, an ill-defined signal abnormality on MRI raised the suspicion for FCD and suggested that similar occult lesions might underlie the epilepsy of her relatives, whose scan results were initially reported as negative. Each patient was thus referred for comprehensive presurgical evaluation. Through the use of advanced neuroimaging, epileptogenic zones were identified in all 3 patients, allowing for targeted resection. At the last follow-up, all had remained seizure free for more than 5 years. LESSONS: When a genetic alteration is associated with FCD, such patients warrant imaging reexamination and exhaustive presurgical evaluation with advanced neuroimaging, as eventual lesion detection and subsequent resection can lead to long-term seizure freedom. https://thejns.org/doi/10.3171/CASE26127